Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin VIAject vs regular human insulin in type 1 diabetes mellitus
2006-006599-39Phase 3Completed
- Sponsor
- Biodel Inc.
- Start
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of VIAject in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Biodel Inc. Started Feb 2007; status: completed.
02
Drugs
VIAject
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2006-006599-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006599-39.